These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33893211)

  • 1. Timing of pacemaker and ICD implantation in
    Ollila LH; Nikus K; Parikka H; Weckström S; Tiina H
    Open Heart; 2021 Apr; 8(1):. PubMed ID: 33893211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family.
    Glöcklhofer CR; Steinfurt J; Franke G; Hoppmann A; Glantschnig T; Perez-Feliz S; Alter S; Fischer J; Brunner M; Rainer PP; Köttgen A; Bode C; Odening KE
    Europace; 2018 Dec; 20(12):2003-2013. PubMed ID: 29947763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient characteristics, predictors and outcome of pacemaker patients upgraded to an implantable cardioverter defibrillator.
    Baldinger SH; Burren D; Noti F; Servatius H; Seiler J; Madaffari A; Asatryan B; Tanner H; Reichlin T; Haeberlin A; Roten L
    Pacing Clin Electrophysiol; 2024 Jun; 47(6):853-861. PubMed ID: 38655610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2015].
    Proclemer A; Zecchin M; D'Onofrio A; Boriani G; Botto GL; Facchin D; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
    G Ital Cardiol (Rome); 2017 Jan; 18(1):67-79. PubMed ID: 28287212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2018].
    Proclemer A; Zecchin M; D'Onofrio A; Boriani G; Ricci RP; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Miconi A; Zorzin AF; Gregori D
    G Ital Cardiol (Rome); 2020 Feb; 21(2):157-169. PubMed ID: 32051640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2017].
    Proclemer A; Zecchin M; D'Onofrio A; Ricci RP; Boriani G; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Miconi A; Zorzin AF; Gregori D
    G Ital Cardiol (Rome); 2019 Mar; 20(3):136-148. PubMed ID: 30821295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2016].
    Proclemer A; Zecchin M; D'Onofrio A; Boriani G; Facchin D; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
    G Ital Cardiol (Rome); 2018 Feb; 19(2):119-131. PubMed ID: 29531385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pacemaker and implantable cardioverter-defibrillator registry of the Italian Association Arrhythmology Cardiac Pacing and cardiac pacing - annual report 2013].
    Proclemer A; Zecchin M; D'Onofrio A; Botto GL; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
    G Ital Cardiol (Rome); 2014 Nov; 15(11):638-50. PubMed ID: 25424143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spanish Implantable Cardioverter-Defibrillator Registry. Third Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (2006)].
    Peinado R; Torrecilla EG; Ormaetxe J; Alvarez M;
    Rev Esp Cardiol; 2007 Dec; 60(12):1290-301. PubMed ID: 18082095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.
    Demir GG; Guler GB; Guler E; Güneş H; Kizilirmak F; Karaca İO; Omaygenç MO; Çakal B; Olgun E; Savur U; Ibisoglu E; Barutçu I; Kiliçaslan F
    Acta Cardiol; 2017 Feb; 72(1):47-52. PubMed ID: 28597740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spanish Implantable Cardioverter-Defibrillator Registry. Fourth Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (2007)].
    Peinado Peinado R; Torrecilla EG; Ormaetxe J; Alvarez M
    Rev Esp Cardiol; 2008 Nov; 61(11):1191-203. PubMed ID: 19000494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study.
    van Rijsingen IA; Arbustini E; Elliott PM; Mogensen J; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Pilotto A; Pasotti M; Jenkins S; Rowland C; Aslam U; Wilde AA; Perrot A; Pankuweit S; Zwinderman AH; Charron P; Pinto YM
    J Am Coll Cardiol; 2012 Jan; 59(5):493-500. PubMed ID: 22281253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of early cardiac resynchronization therapy implantation in dilated cardiomyopathy patients with narrow QRS carrying lamin A/C mutation.
    Blich M; Darawsha W; Eyal A; Shehadeh F; Boulous M; Gepstein L; Suleiman M
    Am J Cardiovasc Dis; 2024; 14(1):47-53. PubMed ID: 38495409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies.
    Saj M; Bilinska ZT; Tarnowska A; Sioma A; Bolongo P; Sobieszczanska-Malek M; Michalak E; Golen D; Mazurkiewicz L; Malek L; Walczak E; Fidzianska A; Grzybowski J; Przybylski A; Zielinski T; Korewicki J; Tesson F; Ploski R
    BMC Med Genet; 2013 May; 14():55. PubMed ID: 23702046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spanish implantable cardioverter-defibrillator registry. Seventh official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2010)].
    Alzueta J; Fernández JM
    Rev Esp Cardiol; 2011 Nov; 64(11):1023-34. PubMed ID: 21967881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter defibrillator therapy in young patients with cardiomyopathies and channelopathies: a single Italian centre experience.
    Migliore F; Silvano M; Zorzi A; Bertaglia E; Siciliano M; Leoni L; De Franceschi P; Iliceto S; Corrado D
    J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):485-93. PubMed ID: 27136702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P; Özer N; Ateş AH; Yorgun H; Oto A; Aytemir K
    Cardiol J; 2015; 22(6):637-44. PubMed ID: 26412607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.